You may also like
Fetal Cardiac Interventions: Where Do We Stand?
Fetal cardiac intervention (FCI) is a novel and evolving technique that allows for in utero treatment of a subset of congenital heart disease.
1 min read
The GP IIb/IIIa Inhibitor Abciximab (ReoPro((R))) Decreases Activation and Interaction of Platelets and Leukocytes During In Vitro Cardiopulmonary Bypass Simulation
The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.
1 min read
Fibrinogen Concentrate Reduces Intraoperative Bleeding when used as First-Line Hemostatic Therapy During Major Aortic Replacement Surgery: Results from a Randomized, Placebo-Controlled Trial
We assessed whether fibrinogen concentrate as targeted first-line hemostatic therapy was more effective than placebo or a standardized transfusion algorithm in controlling coagulopathic bleeding in patients undergoing major aortic surgery.
1 min read